Mesothelioma Widower Receives Bigger Award After Asbestos Company’s Appeal

When a mesothelioma victim opts for legal action against an asbestos company, they do so knowing that the road ahead will be long and challenging. The companies will fight back at every step, objecting to testimony, to the amount a jury awards, and more. In a case recently heard in a New York court room, these tactics backfired on talc provider Whittaker, Clark and Daniels, Inc. when their appeal resulted in the court increasing the amount that they owed to a man who lost his wife to mesothelioma. Continue reading

Exploring Gender Differences in Mesothelioma Patient Survival

Mesothelioma is an equal opportunity illness: It strikes both men and women, though the disease is more prevalent in men, a fact which is attributable to men having greater occupational exposure to the carcinogenic material than women. Men have traditionally worked in environments such as factories and construction, as well as in military settings where asbestos was used to protect against fire, heat and sound. In addition to disparities in the frequency of diagnosis of mesothelioma between men and women, researchers have found that there are also differences in the treatment each receives and their overall survival time. Interestingly, the analysis of survival time and treatment provided seemingly contradictory information. Continue reading

Study Reveals Success of Radical Peritoneal Mesothelioma Surgery

The shock of a diagnosis of malignant peritoneal mesothelioma is quickly replaced by the need for action. There is little time to sit and consider: the fast-moving and fatal asbestos-related cancer needs to be addressed immediately in order to provide patients with the longest possible overall survival and best quality of life. If you or someone you love is a veteran facing this illness, you may want to consider the results of a recent study conducted at Inova Fairfax Hospital, which found that patients undergoing surgery and heated chemotherapy treatment have significantly longer survival times than those who pursue other types of treatment options. Continue reading

Veterans with Mesothelioma May Benefit from Innovative Glowing Dye

When a veteran is diagnosed with malignant mesothelioma, they confer with physicians to determine the best way forward. For many, this path will include surgery to remove the cancer’s tumors and provide them with symptom relief or extended survival, but mesothelioma tumors are notoriously difficult to remove, and cells left behind can lead to metastasis and a faster return of their cancer. To address this issue, researchers from the University of Pennsylvania are investigating the use of a glowing dye that will enhance their ability to detect cells left behind. Continue reading

Study Confirms That Asbestos – Rather than Radiation – Causes Mesothelioma

Malignant mesothelioma is a rare and fatal form of cancer that is diagnosed in military veterans more than any other single cohort — roughly one third of all mesothelioma victims in the United States served in the military. This has long been understood to be a result of the ubiquitous use of asbestos in military applications in the years between World War II and the Iraq and Afghanistan wars.  Despite this, asbestos companies have frequently pointed to radiation as the cause of the disease in an attempt to defend themselves against lawsuits. Now a comprehensive study has conclusively debunked that assertion. Continue reading

Innovative Radiation Therapy Treatments for Veterans with Malignant Mesothelioma

Malignant mesothelioma is a rare form of cancer that is caused by exposure to asbestos. Unfortunately, America’s veterans who served in the years between World War II and the Iraq and Afghanistan wars are at high risk for this disease because of the military’s extensive use of the carcinogenic material. Though mesothelioma is always considered fatal, researchers from all over the world are working towards finding more effective treatments. Continue reading

Veterans with Mesothelioma May Benefit from Genetically Modified Virus

Veterans are diagnosed with malignant mesothelioma – the rare, asbestos-related form of cancer – at a much higher rate than is true of the rest of the population. This is a result of having been exposed to the dangerous mineral during their years of service. Though mesothelioma is always considered fatal, scientists and researchers are working to create innovative new treatments that provide improved quality of life and extended survival. One of the most promising of these is a genetically modified virus known as ONCOS-102. Continue reading

Japanese Study Helps Veterans Understand Mesothelioma Surgery Outcomes

Veterans who were exposed to asbestos during the time of their service are at a high risk for being diagnosed with malignant mesothelioma, the rare and fatal form of cancer. Once diagnosed, they face many important decisions, including whether to go forward with aggressive and invasive surgery to remove their tumors. A group of Japanese researchers recently completed a study that highlights the difference between different surgical options. Continue reading

Veterans’ Burials Impacted by COVID-19

America’s veterans make up a disproportionate percentage of mesothelioma victims, as well as victims of other asbestos-related diseases. As COVID-19 has blazed across the country and the world, it too has struck hard at the veteran population, many of whom are elderly and living in veteran’s homes. Deaths are always a reality, but in the face of the pandemic the number of veterans dying has increased sharply. This has led to an unexpected and significant burden on the federal agency responsible for providing approval for military veterans to be buried in state and national cemeteries. Continue reading

Mesothelioma Outcomes Improve With Multidisciplinary Approach

The type of care that a patient who is diagnosed with malignant mesothelioma receives is dependent upon many different variables. If the patient is a veteran, they generally seek treatment from their local V.A. hospital, and if that hospital does not have the quality of care demanded by their diagnosis, they are able to seek help at more sophisticated cancer treatment centers. The same is not true for many others, who are limited by their proximity to teaching hospitals and major metropolitan facilities. One thing that has become increasingly clear is that the more advanced the cancer center where treatment is provided, the more a patient is likely to be offered a multidisciplinary approach, and a recent study has revealed that patients treated in this way have a much better chance of experiencing an enhanced quality of life and extended survival time. Continue reading